Expression of c-kit in adenoid cystic carcinoma of the breast

American Journal of Clinical Pathology

Volumn 124, Issue 5, 2005, Pages 733-739

  Crisi, Giovanna M ^a,c   Marconi, Sharon A ^a   Makari Judson, Grace ^b   Goulart, Robert A ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAYSTATE HEALTH   (United States)

^c BAYSTATE MEDICAL CENTER   (United States)

Author keywords

Adenoid cystic carcinoma; Breast; c kit

Indexed keywords

STEM CELL FACTOR;

ADENOID CYSTIC CARCINOMA; ADULT; AGED; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; PRIORITY JOURNAL; TUMOR CELL;

EID: 27444441761     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/61MVENEK5EJ7JKGF     Document Type: Article

References (30)

1. Trendell-Smith NJ, Peston D, Shousha S. Adenoid cystic carcinoma of the breast: a tumor commonly devoid of oestrogen receptors and related proteins. Histopathology. 1999;35:241-248.
2. Rosen PP. Adenoid cystic carcinoma. In: Rosen PP. Rosen's Breast Pathology. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001:535-549.
3. Due W, Herbst H, Loy V, et al. Characterization of adenoid cystic carcinoma of the breast by immunohistology. J Clin Pathol. 1989;42:470-476.
4. Besmer P, Murphy JE, George PC, et al. A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Nature. 1986;320:415-421.
5. Holst VA, Marshall CE, Moskaluk CA, et al. KIT protein expression and analysis of c-kit gene mutations in adenoid cystic carcinoma. Mod Pathol. 1999;12:956-960.
6. Jeng YM, Lin CY, Hsu HC. Expression of the c-kit protein is associated with certain subtypes of salivary gland carcinomas. Cancer Lett. 2000;154:107-111,
7. Penner CR, Folpe AL, Budnick SD. c-kit expression distinguishes salivary gland adenoid cystic carcinoma from polymorphous low-grade adenocarcinoma. Mod Pathol. 2002;15:687-691.
8. Ernst SI, Hubbs AE, Przygodzki RM, et al. kit mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors. Lab Invest. 1998;78:1633-1636.
9. Anthony PP, James PD. Adenoid cystic carcinoma of the breast: prevalence, diagnostic criteria, and histogenesis. J Clin Pathol. 1975;28:647-655.
10. Friedman BA, Oberman HA. Adenoid cystic carcinoma of the breast. Am J Clin Pathol. 1970;54:1-14.
11. Ro JY, Silva EG, Gallager HS. Adenoid cystic carcinoma of the breast. Hum Pathol. 1987;18:1276-1281.
12. Chui X, Egami H, Yamashita J, et al. Immunohistochemical expression of the c-kit proto-oncogene product in human malignant and non-malignant breast tissues. Br J Cancer. 1996;73:1233-1236.
13. Natali PG, Nicostra MR, Sures I, et al. Breast cancer is associated with loss of the c-kit oncogene product. Int J Cancer. 1992;52:713-717.
14. Reis-Filho JS, Fulford LG, Crebassa B, et al. Collagenous spherulosis in an adenomyoepithelioma of the breast. J Clin Pathol. 2004;57:83-86.
15. Hill PA. c-kit expression in adenoid cystic carcinoma of the breast [letter]. Pathology. 2004;36:362-364.
16. Matte C, Visscher DW, Reynolds C. c-kit protein expression in adenoid cystic carcinoma of the breast [abstract]. Mod Pathol. 2004;17:158A.
17. Simon R, Panussis S, Maurer R, et al. kit (CD117)-positive breast cancers are infrequent and lack kit gene mutations. Clin Cancer Res. 2004;10:178-183.
18. Went PT, Dirnhofer S, Bundi M, et al. Prevalence of kit expression in human tumors. J Clin Oncol. 2004;22:4514-4522.
19. Yarden Y, Kuang WS, Yang-Feng T, et al. Human protooncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J. 1987;6:3341-3351.
20. Lammie A, Drobnjak M, Gerald W, et al. Expression of c-kit and kit ligand proteins in normal human tissues. J Histochem Cytochem. 1994;42:1417-1425.
21. Tsuura Y, Hiraki H, Watanabe K, et al. Preferential localization of c-kit product in tissue mast cells, basal cells of skin, epithelial cells of breast, small cell lung carcinoma and seminoma/dysgerminoma in human: immunohistochemical study on formalin-fixed, paraffin-embedded tissues. Virchows Arch. 1994;424:135-141.
22. Arber DA, Tamayo R, Weiss LM. Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders. Hum Pathol. 1998;28:498-504.
23. Tsuura Y, Suzuki T, Honma K, et al. Expression of c-kit protein in proliferative lesions of breast: sexual difference and close association with phosphotyrosine status. J Cancer Res Clin Oncol. 2002;128:239-246,
24. Yared MA, Middleton LP, Meric F, et al. Expression of c-kit proto-oncogene product in breast tissue. Breast J. 2004;4:323-327.
25. Palmu S, Soderstrom KO, Quazi K, et al. Expression of c-kit and HER-2 tyrosine kinase receptors in poor-prognosis breast cancer. Anticancer Res. 2002;22:411-414.
26. Chung-Ming C, Cheng-Jueng C, Chun-Liang C, et al. CD34, CD117, and actin expression in phyllodes tumor of the breast. J Surg Res. 2000;94:84-91.
27. Sawyer EJ, Poulsom R, Hunt FT, et al. Malignant phyllodes tumors show stromal overexpression of c-myc and c-kit. J Pathol. 2003;200:59-64.
28. Dabiri S, Huntsman D, Makretsov N, et al. The presence of stromal mast cells identifies a subset of invasive breast cancers with a favorable prognosis. Mod Pathol. 2004;17:690-695.
29. Corless CL, Heinrich MC, Dimitrijevic S, et al. Correlation of imatinib response with activation of kit and PDGF receptors in a variety of cancers: results of the CSTIB2225 trial [abstract]. Proc Am Soc Clin Oncol. 2003;195:783A.
30. Heinrich MC, Corless CL, Von Mehren M, et al. PDGFRA and kit mutations correlate with the clinical responses to imatinib mesylate in patients with advanced gastrointestinal stromal tumors (GIST) [abstract]. Proc Am Soc Clin Oncol. 2003;815:3274A.